Cancer Musings

Season 1, Episode 1

Advancing Precision Oncology for Global Patient Benefit

The podcast «WIN Consortium: Advancing Precision Oncology for Global Patient Benefit» explores the work of the WIN Consortium, a global network of nearly 40 academic, industry, and research institutions, along with patient advocacy groups, dedicated to advancing personalized cancer care. By leveraging artificial intelligence, molecular profiling, and innovative clinical trials like N-of-1 studies, WIN tailors treatments to individual tumor characteristics. The podcast also discusses key challenges in precision oncology, such as drug accessibility, regulatory barriers, and global healthcare disparities, highlighting WIN’s commitment to making cutting-edge treatments available to all patients, regardless of location or financial status.